2024
Long-Term Outcomes of Patients With Apical Hypertrophic Cardiomyopathy Utilizing a New Risk Score
Hajj-Ali A, Gaballa A, Akintoye E, Jadam S, Ramchand J, Xu B, Ospina S, Thamilarasan M, Smedira N, Popovic Z, Desai M. Long-Term Outcomes of Patients With Apical Hypertrophic Cardiomyopathy Utilizing a New Risk Score. JACC Advances 2024, 3: 101235. PMID: 39512540, PMCID: PMC11540864, DOI: 10.1016/j.jacadv.2024.101235.Peer-Reviewed Original ResearchApical hypertrophic cardiomyopathyRight ventricular systolic pressureLeft atrial volume indexAtrial volume indexVentricular systolic pressureRisk scoreApical aneurysmEnd pointsHypertrophic cardiomyopathyMean left ventricle ejection fractionSystolic pressureLong-term outcomes of patientsApical hypertrophic cardiomyopathy patientsVolume indexBaseline cardiac magnetic resonanceComposite primary end pointPrimary end pointOutcomes of patientsVentricle ejection fractionDelayed gadolinium enhancementCardiac magnetic resonanceComposite end pointLong-term outcomesComposite event rateLeft ventricle apex
2021
Short and long term outcomes of cardiac amyloidosis patients listed for heart transplantation in the united states: a propensity-matched analysis
Akintoye E, Alvarez P, Briasoulis A. Short and long term outcomes of cardiac amyloidosis patients listed for heart transplantation in the united states: a propensity-matched analysis. European Heart Journal 2021, 42: ehab724.0965. DOI: 10.1093/eurheartj/ehab724.0965.Peer-Reviewed Original ResearchPost-transplant graft survivalGraft survivalGraft survival ratesPropensity-matched analysisCA patientsHigher waitlist mortalityHeart transplantationCardiac amyloidosis patientsWaitlist mortalityRestrictive cardiomyopathyRisk factorsDonor heartsAmyloidosis patientsSurvival rateStudy periodComparable graft survivalPoor graft survivalPropensity-matched cohortOrgan Sharing databaseSingle-center experienceCohort of patientsPredictors of survivalLong-term outcomesSignificant risk factorsAmyloid recurrence
2020
Characteristics and Outcomes of Patients Undergoing Combined Organ Transplantation (from the United Network for Organ Sharing)
Briasoulis A, Akintoye E, Kuno T, Alvarez P. Characteristics and Outcomes of Patients Undergoing Combined Organ Transplantation (from the United Network for Organ Sharing). The American Journal Of Cardiology 2020, 129: 42-45. PMID: 32540168, DOI: 10.1016/j.amjcard.2020.05.034.Peer-Reviewed Original ResearchMeSH KeywordsAdultBlack or African AmericanCardiomyopathy, DilatedCardiomyopathy, RestrictiveFemaleGraft RejectionHeart Defects, CongenitalHeart FailureHeart TransplantationHeart-Lung TransplantationHispanic or LatinoHumansKidney DiseasesKidney TransplantationLiver DiseasesLiver TransplantationLung DiseasesMaleMiddle AgedMortalityProportional Hazards ModelsRegistriesReoperationSurvival RateWhite PeopleConceptsHeart-liver transplantPrimary heart transplantationLong-term survivalHeart transplantationOrgan transplantsStage D heart failureD heart failureOutcomes of patientsOrgan Sharing registryLong-term outcomesCongenital heart diseaseAdult patientsMedian survivalHeart failureTransplantation ratesUnited NetworkList timeHeart diseaseOperative characteristicsOrgan transplantationSurvival analysisPatientsTransplantInverse probabilityStudy periodTemporal Trends and Outcomes of Patients Undergoing Combined Organ Transplantation: Insights from the United Network for Organ Sharing (UNOS)
Briasoulis A, Akintoye E, Alvarez P. Temporal Trends and Outcomes of Patients Undergoing Combined Organ Transplantation: Insights from the United Network for Organ Sharing (UNOS). The Journal Of Heart And Lung Transplantation 2020, 39: s167-s168. DOI: 10.1016/j.healun.2020.01.1126.Peer-Reviewed Original ResearchHeart-liver transplantPrimary heart transplantationLong-term survivalHeart transplantationUnited NetworkOrgan transplantsStage D heart failureD heart failureMethods Adult patientsOutcomes of patientsOrgan Sharing registryLong-term outcomesCongenital heart diseaseAdult patientsMedian survivalHeart failureTransplantation ratesList timeHeart diseaseOperative characteristicsOrgan transplantationOrgan SharingSurvival analysisPatientsTransplant
2019
P3603Impact of idiopathic thrombocytopenic purpura on clinical outcomes in patients with acute myocardial infarction
Chehab O, Pahuja M, Adegbala O, Akintoye E, Ramia P, Morsi R, Alrojolah L, Mishra T, Shokr M, Kanj A, Abdallah N, Tabaja H, Afonso L, Abidov A. P3603Impact of idiopathic thrombocytopenic purpura on clinical outcomes in patients with acute myocardial infarction. European Heart Journal 2019, 40: ehz745.0462. DOI: 10.1093/eurheartj/ehz745.0462.Peer-Reviewed Original ResearchIdiopathic thrombocytopenic purpuraAcute myocardial infarctionLength of stayLonger LOSNon-ITP patientsAcute ischemic strokeClinical outcomesHospital mortalitySecondary outcomesThrombocytopenic purpuraAMI patientsMyocardial infarctionACC/AHA/ESCUS National Inpatient Sample databaseNational Inpatient Sample databaseCardiovascular risk factorsPropensity-matched cohortLow platelet countManagement of patientsShort-term mortalityLong-term outcomesCoronary revascularization proceduresHospital complicationsMore comorbiditiesAnticoagulation therapy